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Available online 9 March 2016Spinocerebellar ataxia type 3 (SCA3) is a dominantly inherited neurodegenerative disease caused by a CAG-
repeat expanding mutation in ATXN3. We generated induced pluripotent stem cells (iPSCs) from a SCA3 patient
by electroporation of dermal ﬁbroblasts with episomal plasmids encoding L-MYC, LIN28, SOX2, KLF4, OCT4 and
short hairpin RNA targeting P53. The resulting iPSCs had normal karyotype, were free of genomically integrated
episomal plasmids, expressed pluripotency markers, could differentiate into the three germ layers in vitro and
retained the disease-causing ATXN3mutation. This iPSC line could be useful for the investigation of SCA3 disease
mechanisms.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Resource table.und.ku.dk
lls derived from a patient
type 3 (SCA3), CAG-repeat
g SOX2, L-MYC, KLF4, LIN28,
., 2011)
ll line were conﬁrmed by
lysis, pluripotency analysis
-repeat expanding mutation
re/journal/v480/n7378/full/
al., 2011)
the regional scientiﬁc ethical
gion of Denmark and
ned from the patient
. This is an open access article underResource details
Spinocerebellar ataxia type 3 (SCA3) is a dominantly inherited
neurodegenerative disease caused by a mutation expanding the
CAG-repeat of the ATXN3 gene encoding ataxin-3. CAG-repeat length
of disease alleles can vary from 45 to 87 repeats (Matos et al., 2011).
In this study, dermal ﬁbroblasts (named H241) were obtained from a
17-year-old man with spinocerebellar ataxia type 3 (SCA3) with 83
CAG-repeats in the mutant ATXN3 allele. The ﬁbroblasts were
reprogrammed into iPSCs by electroporation with three episomal
plasmids encoding human L-MYC and LIN28, SOX2 and KLF4, and
OCT4 combined with a short hairpin RNA for P53 (shP53). The iPSC
line described in this publication was named SCA3.A11. An addition-
al clone from the same patient termed SCA3.A8 was isolated and
characterized (data not shown). SCA3.A11 had a structurally and
numerically normal karyotype (46, XY) (Fig. 1A) and no integration
of episomal reprogramming plasmids (Fig. 1B). The expression of
the pluripotency genes OCT4, NANOG, SOX2 and LIN28 was upregu-
lated in iPSCs compared to patient ﬁbroblasts (Fig. 1C) and the
gene expression levels were comparable to those of a characterized
positive control iPSC line (Rasmussen et al., 2014). Accordingly, all
SCA3.A11 iPSCs stained positive for the pluripotency markers OCT4,
NANOG, TRA-1-60, TRA-1-81, SSEA-3 and SSEA-4 (Fig. 1D), illustrat-
ing the purity of the iPSC line. Pluripotency was supported by the ca-
pability of SCA3.A11 to differentiate into the three germ layersthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.A. Karyotyping. Representative karyotype of SCA3.A11 iPSCs. B. Integration analysis. Patient ﬁbroblasts (H241) and SCA3.A11 (A11) iPSCs were harvested in duplicates and
DNA was isolated for qRT-PCR with reprogramming plasmid speciﬁc primers. CT-values were normalized to the geometric mean of Hsp90AB1, GUSB and RPL13A and fold change
was calculated relative to ﬁbroblasts using the ΔΔCT-method (Mean ± S.D). C. Gene expression of pluripotency markers. Patient ﬁbroblasts, SCA3.A11 iPSCs and a previously
characterized iPSCs line K2_shP53 (K2) (Rasmussen et al., 2014) were harvested in triplicates and reverse transcribed to cDNA for qRT-PCR. CT-values were normalized to
the geometric mean of Hsp90AB1, GUSB and RPL13A and expression was calculated relative to ﬁbroblasts using the ΔΔCT-method (Mean ± S.D). D. Protein expression of
pluripotency markers. Fluorescent immunocytochemistry for pluripotency markers was performed on SCA3.A11 iPSCs. Cell nuclei were stained with Hoechst. Scalebars:
100 μm. E. In vitro differentiation. Fluorescent immunocytochemistry showing expression of the endodermal marker α-fetoprotein (AFP), the mesodermal marker smooth
muscle actin (SMA) and the ectodermal marker β-III-tubulin (βIIItub) in plated iPSC-derived embryoid bodies. Scalebars: 100 μm. F. Expression of ataxin-3 disease mutation.
Western blot showing the protein expression of ataxin-3 in patient ﬁbroblasts and SCA3.A11. White arrowheads show wild type ataxin-3, while black arrowheads indicate
the expanded form of ataxin-3. GAPDH was used as a loading control.
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expression of the endodermal marker α-fetoprotein (AFP), the me-
sodermal marker smooth muscle actin (SMA) and the ectodermal
marker β-III-tubulin (βIIItub) (Fig. 1E). The identity of SCA3.A11
was conﬁrmed by verifying expression of both normal and expanded
ataxin-3 proteins by western blot (Fig. 1F). Additionally, the CAG-
repeat lengths of the two ataxin-3 alleles were determined to be 23
and 83 repeats in patient ﬁbroblasts and iPSCs by fragment length
analysis (data not shown).Materials and methods
Reprogramming of ﬁbroblasts to iPSCs
Written informed consent was obtained from the SCA3 patient and
the study was approved by the regional scientiﬁc ethical committee in
the Capital Region of Denmark (H-4-2011-157). A skin biopsy was
taken from the forearm of a 17-year-old male SCA3 patient, dissected
and left in ﬁbroblast medium consisting of Dulbecco's modiﬁed eagle's
Table 1
qRT-PCR primers.
Target Forward/Reverse primer (5′–3′)
Episomal plasmids KLF4 Plasmid CCACCTCGCCTTACACATGAAGA
TAGCGTAAAAGGAGCAACATAG
LIN28 Plasmid AGCCATATGGTAGCCTCATGTCCGC
TAGCGTAAAAGGAGCAACATAG
L-MYC Plasmid GGCTGAGAAGAGGATGGCTAC
TTTGTTTGACAGGAGCGACAAT
OCT4 Plasmid CATTCAAACTGAGGTAAGGG
TAGCGTAAAAGGAGCAACATAG
SOX2 Plasmid TTCACATGTCCCAGCACTACCAGA
TTTGTTTGACAGGAGCGACAAT
Pluripotency markers LIN28 AGCCATATGGTAGCCTCATGTCCGC
TCAATTCTGTGCCTCCGGGAGCAGGGTAGG
NANOG TTGGGACTGGTGGAAGAATC
GATTTGTGGGCCTGAAGAAA
OCT4 CCCCAGGGCCCCATTTTGGTACC
ACCTCAGTTTGAATGCATGGGAGAGC
SOX2 TTCACATGTCCCAGCACTACCAGA
TCACATGTGTGAGAGGGGCAGTGTGC
House-keeping genes GUSB TCCGCGCCGACTTCTCTGACA
AAATGCCGCAGACGCCAGTCC
HSP90AB1 TCCGGCGCAGTGTTGGGAC
TCCATGGTGCACTTCCTCAGGC
RPL13A TTCCAAGCGGCTGCCGAAGA
TTCCGGCCCAGCAGTACCTGT
Table 2
Primary antibodies.
Marker of Antigen Specie Dilution Company, catnr.
Pluripotency NANOG Rabbit 1:500 Perprotech, 500-P236
OCT4 Goat 1:200 Santa cruz, sc8628
SSEA-3 Rat 1:200 Biolegend, MC-631
SSEA-4 Mouse 1:200 Biolegend, MC813-70
TRA-1-60 Mouse 1:200 Biolegend, 330602
TRA-1-81 Mouse 1:200 Biolegend, 330702
Mesoderm SMA Mouse 1:500 Dako, M0851
Endoderm AFP Rabbit 1:500 Dako, A0008
Ectoderm βIIItub Mouse 1:4000 Sigma-Aldrich, T8660
Other Ataxin-3 Mouse 1:1000 Millipore, MAB5360
GAPDH Rabbit 1:1000 Abcam, Ab9485
555S.K. Hansen et al. / Stem Cell Research 16 (2016) 553–556medium (DMEM) high glucose (Lonza) with 10% fetal bovine serum
(FBS) (Biological Industries), 2 mM L-glutamine (Lonza) and 1% penicil-
lin–streptomycin (ThermoFisher Scientiﬁc) for 10 days at 37 °C and 5%
CO2 to allow ﬁbroblasts to growout. Prior to reprogramming, ﬁbroblasts
were expanded in ﬁbroblast medium supplemented with 2 ng/ml FGF2
(Sigma-Aldrich). The reprogramming protocol was adopted from a
method published byRasmussen et al. (2014). Brieﬂy, 1 ×105ﬁbroblasts
were electroporated with 1 μg 1:1:1 mix of the episomal plasmids
pCXLE-hUL (L-MYC, LIN28, Adgene #27080), pCXLE-hSK (SOX2, KLF4,
Adgene #27078) and pCXLE-hOCT4-shp53-F (OCT4, shP53, Adgene
#27077) (Okita et al., 2011) using the Neon transfection system
(Invitrogen) with 2 × 20 ms pulses of 1200 V. The electroporated cells
were plated in ﬁbroblast medium without penicillin–streptomycin.
From day 1–8 themediumwas supplemented with 1% penicillin–strep-
tomycin. On day 7 the cells were split 1:2 with trypsin-EDTA (Sigma-Al-
drich) and plated on hESC-qualiﬁed matrigel (BD Biosciences). From
day 8 the cells were cultured in mTeSR1 (Stem Cell Technologies) sup-
plemented with 0.1% penicillin–streptomycin at 37 °C in 5% CO2, 5% O2
and 90% N2. On day 23–31 single iPSC colonies were manually cut and
passaged for expansion. From passage 3 the iPSCs were split every
4–7 days with dispase (ThermoFisher Scientiﬁc). The iPSCs were frozen
inmFreSR1 (Stem Cell Technologies)with 10 μM rock inhibitor (Sigma-
Aldrich). The control iPSC cell line K2_shp53 derived from a healthy
donor was previously characterized by Rasmussen et al. (2014) and
banked in the European Bank of induced Pluripotent Stem Cells
(EBiSC) as BIONi010-B.
Karyotyping
SCA3.A11 iPSCs were treated for 1 h with KaryoMAX colcemid
(ThermoFisher Scientiﬁc) and harvested in ﬁxative containing 25%
acetic acid and 75% methanol. Karyotyping was performed on G-
banded metaphase chromosomes using standard procedures. At least
10metaphaseswere examined per samplewith an approximate resolu-
tion of 400–450 bands per haploid genome.
Integration analysis
DNA was isolated using the DNeasy blood & tissue kit (Qiagen)
according to manufacturer's protocol. The three episomal plasmids
(pCXLE-hUL, pCXLE-hSK and pCXLE-hOCT4-shp53-F) were run as pos-
itive controls to verify function of the plasmid speciﬁc primers (data
not shown). qRT-PCR reactions were run with 2× diluted SsoFast
EvaGreen Supermix (Bio-Rad). CT-values were normalized to the geo-
metric mean of the housekeeping genes Hsp90AB1, GUSB and RPL13A
using the ΔΔCT-method. The plasmid speciﬁc primers are listed in
Table 1.
Quantitative real time polymerase chain reaction (qRT-PCR)
RNA isolation was performed using the RNAeasy mini kit (Qiagen)
according to manufacturer's instructions. 0.5 μg RNA/reaction was re-
verse transcribed using TaqMan reverse transcription reagents (Applied
Biosystems). qRT-PCR reactions were run with SsoFast EvaGreen
Supermix (Bio-Rad) diluted 2×. CT-values were normalized to the geo-
metric mean of the three housekeeping genes Hsp90AB1, GUSB and
RPL13A using the ΔΔCT-method. Primers are listed in Table 1.
In vitro differentiation
The iPSCswere detached in large clumpswith dispase and transferred
to ultra-low adherent plates (Stem Cell Technologies) in mTeSR1 with
10 μM rock inhibitor. After 2 days of culture the medium was changed
to embryoid body (EB)medium consisting of DMEMF12 (Sigma-Aldrich)
supplemented with 20% knockout serum replacement (ThermoFisher
Scientiﬁc), 1× non-essential amino acids (ThermoFisher Scientiﬁc),2 mM glutamax (ThermoFisher Scientiﬁc), 0.1 mM 2-mercaptoethanol
(ThermoFisher Scientiﬁc) and 1% penicillin–streptomycin. After 7 days
EBs were plated on 0.1% gelatin (Sigma-Aldrich) and cultured for
2 weeks in differentiation medium containing DMEM F12 supplemented
with 10% FBS, 2 mM glutamax and 1% penicillin–streptomycin.Fluorescent immunocytochemistry
iPSCs and plated EBs were ﬁxed in 4% paraformaldehyde (Sigma-Al-
drich) for 20 min and washed in PBS. Subsequently, they were perme-
abilized with 0.1% triton X-100 (Sigma-Aldrich) for 15 min, blocked
with 5% normal donkey serum (Millipore, S30) and 1% BSA (Roche)
for 30 min and stained by standard immunoﬂuorescence procedures.
Primary antibodies are listed in Table 2. The following secondary
antibodies were diluted 1:200: Alexa 594 donkey-anti-rat, Alexa 488
donkey-anti-mouse, Alexa 594 donkey-anti-rabbit and Alexa 594
donkey-anti-goat (all from ThermoFisher Scientiﬁc). In addition, cell
nuclei were stained with 0.7 μg/ml Hoechst. Images of plated EBs were
taken with an Evos ﬂ ﬂuorescent microscope. Images of iPSCs were
captured with a Nikon Eclipse Ti 4.10 microscope, Yokogawa CSU-X1
spinning disk confocal scanner. In parallel with analyses of SCA3.A11
iPSCs, patient ﬁbroblasts (H241) were stained as negative controls and
the characterized iPSC line K2_shP53 was used as a positive control
(data not shown).
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Cells were lysed in Ripa buffer (Sigma-Aldrich) supplemented with
1 complete protease inhibitor cocktail tablet (Roche)/40 ml for 10 min
and spun at 15,000 ×g for 10 min. 100 mM DTT (Sigma-Aldrich) and
NuPAGE LDS Sample Buffer (ThermoFisher Scientiﬁc) corresponding
to one fourth of the total sample volume were added to the samples.
Samples were boiled and run on NuPAGE Novex 4–12% Bis-Tris precast
SDS-PAGE gels (ThermoFisher Scientiﬁc) and subsequently blotted onto
Immobilin-FL PVDF membranes (Merck Millipore). The membranes
were blocked in odyssey blocking buffer (LI-COR Biosciences) and incu-
batedwith primary antibody ON at 4 °C (Table 2). After washing in PBS/
0.1% tween-20 (Merck Millipore) the membranes were incubated with
secondary antibodies Alexa Fluor 680 goat-anti-rabbit IgG 1:20,000
(A21077) and Alexa Flour 800 goat-anti-mouse 1:10,000 (926-32210)
(both from ThermoFisher Scientiﬁc) for 1 h at RT. Emitted light was
detected with an infrared Odyssey CLx scanner (LI-COR Odyssey
Biosystems).Fragment length analysis
DNA was isolated with the DNeasy Blood & Tissue Kit (Qiagen)
according to manufactures instructions. The CAG-repeat of the ATXN3
gene was ampliﬁed by PCR using the primers 5′-Fam-TGGCCTTTCACA
TGGATGTGA-3′ and 5′-CCAGTGACTACTTTGATTCG-3′. 1 μl diluted PCR
product, 10 μl formamide (ThermoFisher Scientiﬁc) and 0.5 μl
SizeStandard LIZ-600 (ThermoFisher Scientiﬁc) were mixed and frag-
ment length analysis was performed by capillary electrophoresis on anABI 3130 Genetic Analyzer. Data were analyzed using the Peak scanner
software v1.0 (Applied Biosystems).
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